NasdaqGS:PODDMedical Equipment
Assessing Insulet (PODD) Valuation After Omnipod 5 And Data Platform Expansion In The Middle East
Insulet (PODD) is drawing fresh attention after expanding its Omnipod 5 Automated Insulin Delivery System into Saudi Arabia, Kuwait, Qatar, and the UAE, alongside launching its Omnipod Discover data platform in these markets.
See our latest analysis for Insulet.
Despite fresh attention around the Middle East rollout, Insulet’s recent trading tells a different story, with a 30 day share price return of 15.63% decline and a 1 year total shareholder return of 13.48% decline, suggesting momentum...